Hypervision Surgical
Focus: Hypervision Surgical develops AI-powered hyperspectral imaging systems for surgical applications, currently focused on ophthalmology. The company is a pre-revenue Stage A biotech with a lean team based in London.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
SERIES A
Open Jobs
6+2 this month
Stable — net +2 jobs in 30d
2 added, 0 removed. Backfill posture.
Should You Work at Hypervision Surgical?
AI assessmentJoin only if you have appetite for pre-seed technical risk, deep interest in surgical AI/imaging, and ability to wear multiple hats in a resource-constrained environment.
Why Work Here
- Ground-floor opportunity at an early-stage deep-tech company with a novel imaging platform in an underserved surgical market
- Strong visa sponsorship track record: 10 H1B approvals vs. 2 denials in 2023 signals willingness to recruit global talent
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Hypervision Surgical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.